In conclusion, we postulate a model for the divergent CXCR4-LASP1-AKT1 signaling in breast cancer and CML by differences in LASP1 phosphorylation. This evidence concerns the gene AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive.